| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Surgery (R.A., L.R.), McGill University, Montréal, Québec, Canada H3G 1A4.; and Department of Pharmacology and Therapeutics (R.A., D.M.), McGill University, Montréal, Québec, Canada H3G 1Y6
Address all correspondence and requests for reprints to: Dr. Lawrence Rosenberg, Department of Surgery, Montréal General Hospital, Room C9-128, 1650 Cedar Avenue, Montréal, Québec, Canada H3G 1A4. E-mail: lawrence.rosenberg{at}mcgill.ca.
Therapeutic strategies aimed at the inhibition of specific cell death mechanisms may increase islet yield and improve cell viability and function after routine isolation. The aim of the current study was to explore the possibility of AKT-JNK cross-talk in islets after isolation and the relevance of c-jun NH2-terminal kinases (JNK) suppression on islet survival. After routine isolation, increased AKT activity correlated with suppression of JNK activation, suggesting that they may be related events. Indeed, the increase in AKT activation after isolation correlated with suppression of apoptosis signal-regulating kinase 1 (ASK1), a kinase acting upstream of JNK, by phosphorylation at Ser83. We therefore examined whether modulators of phosphatidylinositol 3-kinase (PI3K)/AKT signaling affected JNK activation. PI3K inhibition led to increased JNK phosphorylation and islet cell death, which could be reversed by the specific JNK inhibitor SP600125. In addition, IGF-I suppressed cytokine-mediated JNK activation in a PI3K-dependent manner. We also demonstrate that inhibition of PI3K rendered islets more susceptible to cytokine-mediated cell death. SP600125 transiently protected islets from cytokine-mediated cell death, suggesting that JNK may not be necessary for cytokine-induced cell death. When administered immediately after isolation, SP600125 improved islet survival and function, even 48 h after removal of SP600125, suggesting that JNK inhibition by SP600125 may be a viable strategy for improving isolated islet survival. Taken together, these results demonstrate that PI3K/AKT suppresses the JNK pathway in islets, and this cross-talk represents an important antiapoptotic consequence of PI3K/AKT activation.
This article has been cited by other articles:
 |
|
 |
|
  D. Mokhtari, J. W. Myers, and N. Welsh The MAPK Kinase Kinase-1 Is Essential for Stress-Induced Pancreatic Islet Cell Death Endocrinology, June 1, 2008; 149(6): 3046 - 3053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Donath, J. Storling, L. A. Berchtold, N. Billestrup, and T. Mandrup-Poulsen Cytokines and {beta}-Cell Biology: from Concept to Clinical Translation Endocr. Rev., May 1, 2008; 29(3): 334 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Autret, S. Martin-Latil, C. Brisac, L. Mousson, F. Colbere-Garapin, and B. Blondel Early Phosphatidylinositol 3-Kinase/Akt Pathway Activation Limits Poliovirus-Induced JNK-Mediated Cell Death J. Virol., April 1, 2008; 82(7): 3796 - 3802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-W. Yang, W.-L. Chen, P.-L. Wu, H.-Y. Tseng, and S.-J. Lee Anti-Inflammatory Mechanisms of Phenanthroindolizidine Alkaloids Mol. Pharmacol., March 1, 2006; 69(3): 749 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. He, H.-T. Cho, W. Li, T. Kawakita, L. Jong, and S. C. G. Tseng Signaling-Transduction Pathways Required for Ex Vivo Expansion of Human Limbal Explants on Intact Amniotic Membrane Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 151 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Lin, T. Gurlo, L. Haataja, W. A. Hsueh, and P. C. Butler Activation of Peroxisome Proliferator-Activated Receptor-{gamma} by Rosiglitazone Protects Human Islet Cells against Human Islet Amyloid Polypeptide Toxicity by a Phosphatidylinositol 3'-Kinase-Dependent Pathway J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6678 - 6686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. R. Healy, N. H. Lee, X. Gao, M. B. Goldring, P. Talalay, T. W. Kensler, and K. Konstantopoulos Divergent responses of chondrocytes and endothelial cells to shear stress: Cross-talk among COX-2, the phase 2 response, and apoptosis PNAS, September 27, 2005; 102(39): 14010 - 14015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Song and Y. J. Lee Cross-talk between JIP3 and JIP1 during Glucose Deprivation: SEK1-JNK2 AND Akt1 ACT AS MEDIATORS J. Biol. Chem., July 22, 2005; 280(29): 26845 - 26855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pelisch, M. Blaustein, A. R. Kornblihtt, and A. Srebrow Cross-talk between Signaling Pathways Regulates Alternative Splicing: A NOVEL ROLE FOR JNK J. Biol. Chem., July 8, 2005; 280(27): 25461 - 25469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Song and Y. J. Lee Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1-MEK-JNK signal transduction pathway during metabolic oxidative stress: a negative feedback loop J. Cell Biol., July 4, 2005; 170(1): 61 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wang, J. Li, K. Lyte, N. K. Yashpal, F. Fellows, and C. G. Goodyer Role for {beta}1 Integrin and Its Associated {alpha}3, {alpha}5, and {alpha}6 Subunits in Development of the Human Fetal Pancreas Diabetes, July 1, 2005; 54(7): 2080 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Rao, J. Roccisana, K. K. Takane, R. Bottino, A. Zhao, M. Trucco, and A. Garcia-Ocana Gene Transfer of Constitutively Active Akt Markedly Improves Human Islet Transplant Outcomes in Diabetic Severe Combined Immunodeficient Mice Diabetes, June 1, 2005; 54(6): 1664 - 1675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Yashpal, J. Li, M. B. Wheeler, and R. Wang Expression of {beta}1 Integrin Receptors during Rat Pancreas Development--Sites and Dynamics Endocrinology, April 1, 2005; 146(4): 1798 - 1807. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
